diazoxide has been researched along with labetalol in 35 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 22 (62.86) | 18.7374 |
1990's | 4 (11.43) | 18.2507 |
2000's | 5 (14.29) | 29.6817 |
2010's | 4 (11.43) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Gifford, RW; Tarazi, RC; Wollam, GL | 1 |
Havard, CW; Pearson, RM | 1 |
Kincaid-Smith, P; Thomas, GW; Whitworth, JA; Yeung, CK | 1 |
Griffith, DN; Havard, CW; James, IM; Pearson, RM; Woollard, M | 1 |
Boakes, AJ; Joekes, AM; Prichard, BN; Thompson, FO | 1 |
Barratt, TM; Deal, JE; Dillon, MJ | 1 |
Bunchman, TE; Lynch, RE; Wood, EG | 1 |
Donen, N; Ewert, FJ; Hudson, RJ; Mutch, WA; Ringaert, KR; White, IW | 1 |
Littler, WA; Smith, SA | 1 |
Naden, RP; Redman, CW | 1 |
Ferguson, RK; Vlasses, PH | 1 |
Vidt, DG | 1 |
Michael, CA | 1 |
Meese, RB; Ram, CV | 1 |
Burris, JF | 1 |
Anand, MP | 1 |
Lubbe, WF | 1 |
Ram, CV | 1 |
Song, YC | 1 |
Binswanger, U; Keusch, G; Schiffl, H | 1 |
Bagatin, J; Rumboldt, Z; Vidovic, A | 2 |
Cressman, MD; Gifford, RW; Moore, WS; Vidt, DG; Wilson, DJ | 1 |
Dage, RC; Hsieh, CP | 1 |
Morgenstern, BZ | 1 |
Marik, PE; Varon, J | 1 |
10 review(s) available for diazoxide and labetalol
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Antihypertensive drugs: clinical pharmacology and therapeutic use.
Topics: Adrenergic beta-Antagonists; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Clonidine; Diazoxide; Diuretics; Ganglionic Blockers; Humans; Hydralazine; Hypertension; Labetalol; Methyldopa; Minoxidil; Monoamine Oxidase Inhibitors; Nitroprusside; Potassium; Prazosin; Secologanin Tryptamine Alkaloids; Sympatholytics | 1977 |
Antihypertensive agents--the race for third place.
Topics: Adrenergic alpha-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Captopril; Diazoxide; Felodipine; Humans; Hydralazine; Indoramin; Labetalol; Minoxidil; Nicardipine; Nifedipine; Vasodilator Agents; Verapamil | 1985 |
Antihypertensive drugs in pregnancy.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Diazoxide; Diuretics; Female; Fetus; Humans; Hydralazine; Hypertension; Labetalol; Methyldopa; Nifedipine; Placenta; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Cardiovascular; Regional Blood Flow; Uterus | 1985 |
Hypertensive emergencies and urgencies.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Clonidine; Diazoxide; Emergencies; Humans; Hydralazine; Hypertension; Hypertension, Malignant; Labetalol; Nitroglycerin; Nitroprusside; Risk; Trimethaphan | 1986 |
Hypertensive cardiovascular emergencies.
Topics: Antihypertensive Agents; Brain Diseases; Cerebrovascular Disorders; Clonidine; Coronary Disease; Diazoxide; Diuretics; Eclampsia; Emergencies; Female; Humans; Hypertension; Hypertension, Malignant; Labetalol; Minoxidil; Nifedipine; Nitroprusside; Pregnancy; Pulmonary Edema; Trimethaphan | 1985 |
Hypertension--drug management.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Calcium Channel Blockers; Captopril; Diazoxide; Humans; Hypertension; Indoramin; Labetalol; Minoxidil; Nifedipine; Nitroprusside; Prazosin; Sympatholytics; Vasodilator Agents; Verapamil | 1982 |
Hypertension in pregnancy. Pathophysiology and management.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Calcium Channel Blockers; Captopril; Clonidine; Diazoxide; Diuretics; Drug Therapy, Combination; Female; Fetal Diseases; Hemodynamics; Humans; Hydralazine; Hypertension; Hypnotics and Sedatives; Labetalol; Magnesium Sulfate; Pregnancy; Pregnancy Complications, Cardiovascular; Reserpine; Sympatholytics; Tranquilizing Agents | 1984 |
Hypertensive crisis.
Topics: Antihypertensive Agents; Brain Diseases; Cerebrovascular Disorders; Clonidine; Coronary Disease; Diazoxide; Eclampsia; Emergencies; Female; Humans; Hydralazine; Hypertension; Hypertension, Malignant; Labetalol; Minoxidil; Nifedipine; Nitroprusside; Phentolamine; Prazosin; Pregnancy; Pulmonary Edema; Trimethaphan | 1984 |
The diagnosis and management of hypertensive crises.
Topics: Antihypertensive Agents; Aortic Aneurysm; Aortic Dissection; Clonidine; Diazoxide; Enalaprilat; Female; Fenoldopam; Humans; Hypertension; Labetalol; Nicardipine; Nifedipine; Nitroprusside; Phentolamine; Pre-Eclampsia; Pregnancy; Propanolamines; Trimethaphan | 2000 |
7 trial(s) available for diazoxide and labetalol
Article | Year |
---|---|
Comparison of effects on cerebral blood flow of rapid reduction in systemic arterial pressure by diazoxide and labetalol in hypertensive patients: preliminary findings.
Topics: Blood Pressure; Cardiac Output; Cerebrovascular Circulation; Diazoxide; Electrocardiography; Ethanolamines; Humans; Hypertension; Labetalol; Male; Middle Aged; Pulse; Stroke Volume | 1979 |
Some haemodynamic effects of compound AH 5158 compared with propranolol, propranolol plus hydrallazine, and diazoxide: the use of AH 5158 in the treatment of hypertension.
Topics: Blood Pressure; Cardiac Output; Clinical Trials as Topic; Diazoxide; Drug Therapy, Combination; Ethanolamines; Heart Rate; Humans; Hydralazine; Hypertension; Labetalol; Physical Exertion; Posture; Propranolol | 1975 |
Continuous opioid infusions for neurosurgical procedures: a double-blind comparison of alfentanil and fentanyl.
Topics: Adult; Aged; Alfentanil; Anesthesia Recovery Period; Anesthesia, Intravenous; Blood Pressure; Consciousness; Craniotomy; Diazoxide; Double-Blind Method; Fentanyl; Heart Rate; Humans; Hypertension; Infusions, Intravenous; Labetalol; Middle Aged; Postoperative Complications; Respiration; Supratentorial Neoplasms; Time Factors | 1991 |
Intravenous labetalol and intravenous diazoxide in severe hypertension complicating pregnancy.
Topics: Adolescent; Adult; Birth Weight; Clinical Trials as Topic; Delivery, Obstetric; Diazoxide; Female; Humans; Hypertension; Infant, Newborn; Infusions, Parenteral; Labetalol; Pregnancy; Pregnancy Complications, Cardiovascular; Prospective Studies; Random Allocation | 1986 |
Diazoxide and labetalol in acute hypertension during haemodialysis.
Topics: Adult; Aged; Blood Pressure; Diazoxide; Ethanolamines; Female; Humans; Hypertension; Labetalol; Male; Middle Aged; Pulse; Renal Dialysis | 1983 |
Diazoxide vs labetalol: a cross-over comparison of short-term effects in hypertension.
Topics: Adult; Aged; Blood Glucose; Blood Pressure; Diazoxide; Drug Evaluation; Ethanolamines; Female; Heart Rate; Humans; Hypertension; Labetalol; Male; Middle Aged; Potassium; Random Allocation | 1983 |
[Diazoxide vs. labetalol: a cross-over comparison of acute effects in hypertensive patients (author's transl)].
Topics: Adolescent; Adult; Aged; Clinical Trials as Topic; Diazoxide; Ethanolamines; Female; Humans; Hypertension; Labetalol; Male; Middle Aged | 1980 |
18 other study(ies) available for diazoxide and labetalol
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Treatment of severe and resistant hypertension.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Clonidine; Diazoxide; Diet, Sodium-Restricted; Diuretics; Humans; Hydralazine; Hypertension; Injections, Intravenous; Labetalol; Methyldopa; Nitroprusside; Patient Dropouts; Trimethaphan; Vasodilator Agents | 1978 |
Comparison of labetalol, clonidine and diazoxide intravenously administered in severe hypertension.
Topics: Adult; Clonidine; Diazoxide; Ethanolamines; Female; Humans; Hypertension; Injections, Intravenous; Labetalol; Male | 1979 |
Management of hypertensive emergencies.
Topics: Adolescent; Child; Child, Preschool; Diazoxide; Emergencies; Female; Humans; Hydralazine; Hypertension; Infant; Infusions, Intravenous; Injections, Intramuscular; Labetalol; Male; Nitroprusside | 1992 |
Intravenously administered labetalol for treatment of hypertension in children.
Topics: Adolescent; Child; Child, Preschool; Creatinine; Diazoxide; Heart Rate; Humans; Hydralazine; Hypertension; Infusions, Intravenous; Labetalol; Nifedipine; Nitroprusside; Potassium; Time Factors | 1992 |
Current concepts in treatment of hypertensive emergencies.
Topics: Diazoxide; Drug Therapy, Combination; Emergencies; Humans; Hydralazine; Hypertension; Labetalol; Methyldopa; Nitroglycerin; Nitroprusside; Phentolamine; Reserpine; Sympathomimetics; Trimethaphan; Vasodilator Agents | 1986 |
Drugs for hypertensive emergencies.
Topics: Administration, Oral; Captopril; Clonidine; Diazoxide; Emergencies; Humans; Hydralazine; Hypertension; Infusions, Parenteral; Labetalol; Nifedipine; Nitroprusside; Trimethaphan | 1985 |
Hypertensive emergencies.
Topics: Antihypertensive Agents; Blood Pressure; Clonidine; Diazoxide; Emergencies; Humans; Hydralazine; Hypertension; Hypertension, Malignant; Labetalol; Nitroprusside; Propranolol; Risk; Trimethaphan | 1985 |
[Clinical use of new antihypertensives].
Topics: Alkaloids; Antihypertensive Agents; Benzylisoquinolines; Captopril; Diazoxide; Diterpenes; Humans; Hypertension; Labetalol; Minoxidil; Nifedipine; Nitroprusside; Prazosin | 1984 |
Intravenous labetalol in the management of severe hypertension and hypertensive emergencies.
Topics: Adolescent; Adult; Aged; Blood Pressure; Diazoxide; Ethanolamines; Female; Humans; Hypertension; Injections, Intravenous; Labetalol; Male; Middle Aged; Nitroprusside; Pulse | 1984 |
Direct vasodilatation by labetalol in anaesthetized dogs.
Topics: Adrenalectomy; Anesthesia; Animals; Clonidine; Diazoxide; Dogs; Ethanolamines; Female; Hemodynamics; Hydralazine; Labetalol; Male; Vagotomy; Vasodilator Agents | 1980 |
Dosage guidelines for pediatric hypertension.
Topics: Child; Diazoxide; Humans; Hypertension; Labetalol | 1995 |